AH
Andreas Halvorsen (Viking Global) disclosed decreased in NEWAMSTERDAM PHARMA COMPANY
Andreas Halvorsen (Viking Global) filed a 13F change in NEWAMSTERDAM PHARMA COMPANY (N62509109) on 2026-05-15, covering period end 2026-03-31.
Action
Decreased
Capital
$12,904,950 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.